Pharma
Award-winning OrganOx acquired by global MedTech company for $1.5Bn
OrganOx, a University of Oxford spin-out, has been acquired by global MedTech company, Terumo, for $1.5 billion. This comes after OrganOx recently won the prestigious Royal Academy of Engineering MacRobert Award for its pioneering devices that keep donor livers and kidneys alive outside...
Excellence First Enterprise Consultancy (EFEC) Perspective: Insights from JD Health’s 2025 Performance
Reflections on the Chinese Healthtech Market and Contextual Considerations for the UK Life Sciences and Healthcare Community ...
Guardtech elevating cleanroom design capabilities through collaboration, co-ordination and utilisation of elite digital tools
Guardtech Group Design Manager Jack Burrow explains how the Suffolk-based cleanroom construction experts are embracing new technology and methodologies to take their project provision to new heights ...
Clinical insights: Respiratory care digital innovation opportunities
Co-authored by Dr Bipin Patel, CEO, electronRx, Cambridge, UK and Dr Hiromichi Yamaguchi, Yamaguchi Respiratory Clinic and Dermatology, Tokyo, Japan. ...
From complexity to clarity: analytics in cell and gene therapy
Cell and gene therapies (CGTs) have redefined the treatment landscape, but their development and manufacturing remain uniquely challenging. They involve variable starting materials and complex, small-scale processes. As the field pushes for faster development, scalable manufacturing and...
NPZ Technology and CCV to showcase cross-border innovation at Cambridge Tech Week 2025
As Innovation Zone Sponsors at Cambridge Tech Week 2025, NPZ Technology Ltd and Cambridge Collaborative Ventures Ltd (CCV) will host an exhibition zone in Innovation Alley, featuring five cross-border innovation companies in digital health, VR, robotics, and AI. ...
Radiotherapy and surgical ablation technologies for cancer treatment
Radiotherapy, or radiation ablation, has evolved significantly since its inception. Ongoing technological advancements have the potential to position radiotherapy as a first-line “surgical” treatment for solid tumours by enhancing its precision and efficacy. Further advancements in real...
Panel Session & Innovation Tour at PA Consulting, 2nd Sept
Join Cambridge Network for an exclusive visit to PA Consulting, a global innovation and transformation consultancy where ingenious ideas are turned into physical and digital reality.Panel Session: ‘Secrets to a Successful Start-Up No One Talks About’ ...
Preventing patient hospitalisation through better stratification and timely intervention
In the realm of healthcare, patient hospitalisation can often be avoided through timely intervention and appropriate medication management. One powerful strategy to achieve this is patient stratification—classifying patients into different groups based on their vulnerability to hos...
Milner Therapeutics Institute featured in AstraZeneca-University of Cambridge partnership impact report
The Milner Therapeutics Institute is delighted to be featured in a new report celebrating a decade of partnership and impact between AstraZeneca and the University of Cambridge ...